Abstract: A salt sampling apparatus includes a containment cell and plunger. The containment cell defines a cell volume, an upper cell mating feature and a lower cell mating feature within the cell volume, and a through-bore extending completely through the containment cell. The plunger is arrangeable within the cell volume along the through-bore and defines a shaft portion, and an upper plunger mating feature and a lower plunger mating feature. The lower plunger mating feature defines a well about the shaft portion configured to receive a volume of a molten salt material. The plunger is moveable between a first position in which the well is positioned substantially out of the cell volume, and a second position in which the well is positioned substantially in the cell volume with the well sealed within the containment volume by the engagement of the containment cell and the plunger.

Abstract: A quantum key distribution system comprises: a transmitter (10) arranged to transmit a coded photon stream over a free space quantum channel (14), wherein the transmitter comprises a single photon source (30) arranged to generate a coded photon stream comprising photons representing QKD bit values, and attenuation means (32) arranged to attenuate the coded photon stream, the attenuation means being variable so as to provide a variable attenuation of the coded photon stream; a receiver (12) arranged to receive the coded photon stream from the quantum channel; and control means (34, 46) arranged to control the attenuation means so as to vary the attenuation.

Abstract: A plant and process are used to liquefy and purify a high pressure ethane feed stream. The plant includes a cascaded refrigeration system that refrigerates the ethane feed stream. The refrigeration system includes a propylene circuit, an ethylene circuit and a mixed refrigerant circuit. The mixed refrigerant circuit includes a refrigerant that includes ethane and methane. The plant includes a demethanizer that is configured to remove methane and other natural gas liquids from the refrigerated ethane stream.

Abstract: A plant and process are used to liquefy and purify a high pressure ethane feed stream. The plant includes a cascaded refrigeration system that refrigerates the ethane feed stream. The refrigeration system includes a propylene circuit, an ethylene circuit and a mixed refrigerant circuit. The mixed refrigerant circuit includes a refrigerant that includes ethane and methane. The plant includes a demethanizer that is configured to remove methane and other natural gas liquids from the refrigerated ethane stream.

Abstract: The subject invention provides methods of screening compounds or ligands that interact with human and/or non-human PAQR receptors or fungal osmotin receptors. These methods utilize a colorimetric assay to ascertain whether a compound binds to and activates a PAQR receptor or the osmotin receptor.

Abstract: A system and method of administering, tracking and managing of claims processing.

Abstract: A system and method of administering, tracking and managing of claims processing.

Abstract: The subject invention provides methods of screening compounds or ligands that interact with human and/or non-human PAQR receptors or fungal osmotin receptors. These methods utilize a colorimetric assay to ascertain whether a compound binds to and activates a PAQR receptor or the osmotin receptor.

Abstract: The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment). Additionally, the present invention demonstrates that specific forms of selenium (e.g., SEL-PLEX), when administered to a subject, possess the ability to alter (e.g., reduce) gene expression in various tissues (e.g., compared to expression in subjects not administered selenium).

Abstract: The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment for neurodegenerative disease). Additionally, the present invention demonstrates that specific forms of selenium (e.g., SEL-PLEX) possess the ability to alter expression of genes associated with disease and/or aging while other forms of selenium (e.g., selenomethionine) do not.

Abstract: The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment for neurodegenerative disease). Additionally, the present invention demonstrates that specific forms of selenium (e.g., SEL-PLEX) possess the ability to alter expression of genes associated with disease and/or aging while other forms of selenium (e.g., selenomethionine) do not.

Abstract: The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment for neurodegenerative disease). Additionally, the present invention demonstrates that specific forms of selenium (e.g., SEL-PLEX) possess the ability to alter expression of genes associated with disease and/or aging while other forms of selenium (e.g., selenomethionine) do not.

Abstract: The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium (e.g., SEL-PLEX) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment for neurodegenerative disease). Additionally, the present invention demonstrates that specific forms of selenium (e.g., SEL-PLEX) possess the ability to alter expression of genes associated with disease and/or aging while other forms of selenium (e.g., selenomethionine) do not.

Abstract: An improved dough-rolling apparatus and method for rolling sheeted dough. The proposed invention comprises a dough-rolling apparatus having a dough sheeter, a sheeting conveyor having a ramped section, a roll-initiating curtain positioned above the ramped section, and a roll-completing curtain positioned above the conveyor and downstream from the roll-initiating conveyor. Sheeted and cut dough pieces are deposited onto a steel mesh, partially-ramped sheeter belt, where two wire-mesh rolling curtains are draped onto the sheeter belt to induce rolling of the dough pieces.

Abstract: A containment apparatus for a multi-pass oven consisting of guide rails and tapered guide chutes having side rails. A tapered guide chute directs product pieces from one conveyor to the center of a receiving region of an underlying conveyor. Guide rails are placed along the sides of the receiving region of an underlying conveyor and maintain baking product pieces on the conveyor. Diverters on the distal end of each guide rail further move product pieces toward the center of the conveyor. Such diverters help ensure that pieces reach a subsequent guide chute or subsequent conveyor without falling off of the conveyor. Such guide rails, diverters, and guide chutes help prevent damage to, and loss of, product pieces while pieces pass through the oven. Guide rails, diverters, and guide chutes are particularly effective at maintaining round or cylindrical pieces within a multi-pass oven.

Abstract: A system and method of administering, tracking and managing of claims processing.